{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:55:24Z","timestamp":1791276924699,"version":"4.1.0"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T00:00:00Z","timestamp":1500854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["FCT-ANR\/BIM-ONC\/0009\/2013"],"award-info":[{"award-number":["FCT-ANR\/BIM-ONC\/0009\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Faculdade de Medicina da Universidade de Lisboa (PT)","award":["GAPIC 2012009 GAPIC 20130041"],"award-info":[{"award-number":["GAPIC 2012009 GAPIC 20130041"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0181065","type":"journal-article","created":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T13:40:00Z","timestamp":1500903600000},"page":"e0181065","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Short (16-mer) locked nucleic acid splice-switching oligonucleotides restore dystrophin production in Duchenne Muscular Dystrophy myotubes"],"prefix":"10.1371","volume":"12","author":[{"given":"Vanessa Borges","family":"Pires","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamel","family":"Mamchaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5980-595X","authenticated-orcid":true,"given":"C\u00e9lia","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Carmo-Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,7,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.coph.2015.07.005","article-title":"An overview of the clinical application of antisense oligonucleotides for RNA-targeting therapies","volume":"24","author":"G McClorey","year":"2015","journal-title":"Curr Opin Pharmacol"},{"key":"ref2","first-page":"533","article-title":"Eteplirsen in the treatment of Duchenne muscular dystrophy","author":"KRQ Lim","year":"2017","journal-title":"Drug Des Devel Ther"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nn.4508","article-title":"Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy","volume":"20","author":"DR Corey","year":"2017","journal-title":"Nat Neurosci"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: The protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"EP Hoffman","year":"1987","journal-title":"Cell"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ncl.2014.05.002","article-title":"Duchenne and Becker muscular dystrophies","volume":"32","author":"KM Flanigan","year":"2014","journal-title":"Neurol Clin"},{"key":"ref6","first-page":"498","article-title":"The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion","volume":"45","author":"M Koenig","year":"1989","journal-title":"Am J Hum Genet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/humu.20918","article-title":"Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations","volume":"30","author":"A Aartsma-Rus","year":"2009","journal-title":"Hum Mutat"},{"key":"ref8","article-title":"Systemic administration of PRO051 in Duchenne\u2019s muscular dystrophy","author":"NM Goemans","year":"2011","journal-title":"The New England journal of medicine"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(11)60756-3","article-title":"Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: An open-label, phase 2, dose-escalation study","volume":"378","author":"S Cirak","year":"2011","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ana.23982","article-title":"Eteplirsen for the treatment of Duchenne muscular dystrophy","volume":"74","author":"JR Mendell","year":"2013","journal-title":"Ann Neurol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S1474-4422(14)70195-4","article-title":"Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): An exploratory, randomised, placebo-controlled phase 2 study","volume":"13","author":"T Voit","year":"2014","journal-title":"Lancet Neurol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.addr.2015.05.008","article-title":"Exon skipping therapy for Duchenne muscular dystrophy","volume":"87","author":"R Kole","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"ref13","unstructured":"FDA summary review. Exondys 51 injection (eteplirsen). Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.accessdata.fda.gov\" xlink:type=\"simple\">www.accessdata.fda.gov<\/ext-link>."},{"key":"ref14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/B978-0-12-407676-1.00002-0","article-title":"Biological Activity and Biotechnological Aspects of Locked Nucleic Acids","volume":"82","author":"KE Lundin","year":"2013","journal-title":"Adv Genet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1039\/a708608c","article-title":"LNA (locked nucleic acids): synthesis and high-affinity nucleic acid recognition","author":"SK Singh","year":"1998","journal-title":"Chem Commun"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"8735","DOI":"10.1016\/S0040-4039(97)10322-7","article-title":"Synthesis of 2\u2032-O,4\u2032-C-methyleneuridine and -cytidine. Novel bicyclic nucleosides having a fixed C<sub>3<\/sub>, -endo sugar puckering","volume":"38","author":"S Obika","year":"1997","journal-title":"Tetrahedron Lett"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1074-5521(00)00058-2","article-title":"Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA","volume":"8","author":"DA Braasch","year":"2001","journal-title":"Chem Biol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1002\/1521-3765(20000804)6:15<2687::AID-CHEM2687>3.0.CO;2-U","article-title":"Structural Studies of LNA:RNA Duplexes by NMR: Conformations and Implications for RNase H Activity","volume":"6","author":"K Bondensgaard","year":"2000","journal-title":"Chemistry"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"13233","DOI":"10.1021\/bi0485732","article-title":"LNA (Locked Nucleic Acid): High-Affinity Targeting of Complementary RNA and DNA","volume":"43","author":"B Vester","year":"2004","journal-title":"Biochemistry"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.1093\/nar\/gkq457","article-title":"Short locked nucleic acid antisense oligonucleotides potently reduce apolipoprotein B mRNA and serum cholesterol in mice and non-human primates","volume":"38","author":"EM Straarup","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0107487","article-title":"Knock-down of IL-1Ra in obese mice decreases liver inflammation and improves insulin sensitivity","volume":"9","author":"N Franck","year":"2014","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.antiviral.2014.08.015","article-title":"Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients","volume":"111","author":"MH van der Ree","year":"2014","journal-title":"Antiviral Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1042\/BJ20080013","article-title":"Splice-switching efficiency and specificity for oligonucleotides with locked nucleic acid monomers","volume":"412","author":"P Guterstam","year":"2008","journal-title":"Biochem J"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/sj.gt.3302313","article-title":"Comparative analysis of antisense oligonucleotide analogs for targeted DMD exon 46 skipping in muscle cells","volume":"11","author":"A Aartsma-Rus","year":"2004","journal-title":"Gene Ther"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/mt.2008.85","article-title":"An endogenous TNF-alpha antagonist induced by splice-switching oligonucleotides reduces inflammation in hepatitis and arthritis mouse models","volume":"16","author":"MA Graziewicz","year":"2008","journal-title":"Mol Ther"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/nar\/gkh187","article-title":"Nuclear antisense effects in cyclophilin A pre-mRNA splicing by oligonucleotides: a comparison of tricyclo-DNA with LNA","volume":"32","author":"D Ittig","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ymthe.2006.05.017","article-title":"Efficient and Persistent Splice Switching by Systemically Delivered LNA Oligonucleotides in Mice","volume":"14","author":"J Roberts","year":"2006","journal-title":"Mol Ther"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1038\/mtna.2012.58","article-title":"Inhibition of IL-1 Signaling by Antisense Oligonucleotide-mediated Exon Skipping of IL-1 Receptor Accessory Protein (IL-1RAcP)","volume":"2","author":"AS Yilmaz-Elis","year":"2013","journal-title":"Mol Ther Nucleic Acids"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"8174","DOI":"10.1093\/nar\/gku512","article-title":"Design and evaluation of locked nucleic acid-based splice-switching oligonucleotides in vitro","volume":"42","author":"T Shimo","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"D710","DOI":"10.1093\/nar\/gkv1157","article-title":"Ensembl 2016","volume":"44","author":"A Yates","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1101\/gr.229102","article-title":"The Human Genome Browser at UCSC W","volume":"12","author":"WJ Kent","year":"2002","journal-title":"Genome Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/2044-5040-1-34","article-title":"Immortalized pathological human myoblasts: towards a universal tool for the study of neuromuscular disorders","volume":"1","author":"K Mamchaoui","year":"2011","journal-title":"Skelet Muscle"},{"key":"ref33","first-page":"e43","article-title":"Long-term Exon Skipping Studies With 2\u2019-O-Methyl Phosphorothioate Antisense Oligonucleotides in Dystrophic Mouse Models","volume":"1","author":"CL Tanganyika-de Winter","year":"2012","journal-title":"Mol Ther Nucleic Acids Nucleic Acids"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0002-9440(10)65354-0","article-title":"Multiplex Western blotting system for the analysis of muscular dystrophy proteins","volume":"154","author":"L V Anderson","year":"1999","journal-title":"Am J Pathol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/mt.2008.205","article-title":"Guidelines for antisense oligonucleotide design and insight into splice-modulating mechanisms","volume":"17","author":"A Aartsma-Rus","year":"2009","journal-title":"Mol Ther"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/mt.2008.287","article-title":"Design of Phosphorodiamidate Morpholino Oligomers (PMOs) for the Induction of Exon Skipping of the Human DMD Gene","volume":"17","author":"LJ Popplewell","year":"2009","journal-title":"Mol Ther"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1089\/hum.2011.205","article-title":"A Prospective Study in the Rational Design of Efficient Antisense Oligonucleotides for Exon Skipping in the DMD Gene","volume":"23","author":"ZA Pramono","year":"2012","journal-title":"Hum Gene Ther"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/oli.2009.0215","article-title":"Exonic Sequences Provide Better Targets for Antisense Oligonucleotides Than Splice Site Sequences in the Modulation of Duchenne Muscular Dystrophy Splicing","volume":"20","author":"A Aartsma-Rus","year":"2010","journal-title":"Oligonucleotides"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/333466a0","article-title":"The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle","volume":"333","author":"EE Zubrzycka-Gaarn","year":"1988","journal-title":"Nature"},{"issue":"Suppl 1","key":"ref40","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/S0960-8966(02)00086-X","article-title":"Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy","volume":"12","author":"A Aartsma-Rus","year":"2002","journal-title":"Neuromuscular Disorders"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1056\/NEJMoa073108","article-title":"Local dystrophin restoration with antisense oligonucleotide PRO051","volume":"357","author":"JC van Deutekom","year":"2007","journal-title":"N Engl J Med"},{"issue":"8","key":"ref42","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/hmg\/ddg100","article-title":"Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients","volume":"12","author":"A Aartsma-Rus","year":"2003","journal-title":"Hum Mol Genet"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1011367","article-title":"Systemic administration of PRO051 in Duchenne\u2019s muscular dystrophy","volume":"364","author":"NM Goemans","year":"2011","journal-title":"N Engl J Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0120058","article-title":"In silico screening based on predictive algorithms as a design tool for exon skipping oligonucleotides in duchenne muscular dystrophy","volume":"10","author":"Y Echigoya","year":"2015","journal-title":"PLoS One"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/sj.mt.6300095","article-title":"Antisense oligonucleotide-induced exon skipping across the human dystrophin gene transcript","volume":"15","author":"SD Wilton","year":"2007","journal-title":"Mol Ther"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/oli.2005.15.284","article-title":"Functional analysis of 114 exon-internal AONs for targeted DMD exon skipping: indication for steric hindrance of SR protein binding sites","volume":"15","author":"A Aartsma-Rus","year":"2005","journal-title":"Oligonucleotides"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1186\/gb-2013-14-12-r143","article-title":"The evolution, impact and properties of exonic splice enhancers","volume":"14","author":"EF Caceres","year":"2013","journal-title":"Genome Biol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1093\/molbev\/msu249","article-title":"Purifying selection on splice-related motifs, not expression level nor RNA folding, explains nearly all constraint on human lincRNAs","volume":"31","author":"A Sch\u00fcler","year":"2014","journal-title":"Mol Biol Evol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/gt.2011.100","article-title":"Chemical modification and design of anti-miRNA oligonucleotides","volume":"18","author":"KA Lennox","year":"2011","journal-title":"Gene Ther"},{"key":"ref50","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/707323","article-title":"Superior silencing by 2\u2019,4\u2019-BNA(NC)-based short antisense oligonucleotides compared to 2\u2019,4\u2019-BNA\/LNA-based apolipoprotein B antisense inhibitors","volume":"2012","author":"T Yamamoto","year":"2012","journal-title":"J Nucleic Acids"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1093\/nar\/23.17.3578","article-title":"Design, biochemical, biophysical and biological properties of cooperative antisense oligonucleotides","volume":"23","author":"ER Kandimalla","year":"1995","journal-title":"Nucleic Acids Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/ng.786","article-title":"Silencing of microRNA families by seed-targeting tiny LNAs","volume":"43","author":"S Obad","year":"2011","journal-title":"Nat Genet"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0181065","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T18:03:57Z","timestamp":1588961037000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0181065"}},"subtitle":[],"editor":[{"given":"Emanuele","family":"Buratti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,7,24]]},"references-count":52,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0181065","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,24]]}}}